Site icon The Blind Machine

BioNTech aims to develop the first mRNA malaria vaccine as well as the capacity to produce it in Africa

Reuters/James Gathany/CDCAfrica stands to benefit the most from a malaria vaccine given the high prevalence rates.

https://qz.com/africa/2040120/biontech-to-develop-the-first-mrna-malaria-vaccine/

Exit mobile version